Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For August 7, 2018

Share:

Top Upgrades

  • Morgan Stanley upgraded Illumina, Inc. (NASDAQ: ILMN) from Underweight to Equal-Weight. Illumina shares rose 1.7 percent to $338.02 in pre-market trading.
  • Analysts at Stifel Nicolaus upgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from Hold to Buy. Alnylam Pharmaceuticals shares rose 1.55 percent to close at $93.07 on Monday.
  • Baird upgraded MasTec, Inc. (NYSE: MTZ) from Neutral to Outperform. MasTec shares fell 0.54 percent to close at $46.45 on Monday.
  • Macquarie upgraded SeaWorld Entertainment Inc (NYSE: SEAS) from Underperform to Neutral. SeaWorld shares rose 1.26 percent to $25.00 in pre-market trading.

 

Top Downgrades

  • Mizuho downgraded PulteGroup, Inc. (NYSE: PHM) from Buy to Neutral. PulteGroup shares rose 0.28 percent to close at $28.72 on Monday.
  • BTIG Research downgraded CBL & Associates Properties, Inc (NYSE: CBL) from Neutral to Sell. CBL & Associates shares fell 3.31 percent to $4.53 in pre-market trading.
  • Stifel Nicolaus downgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) from Buy to Hold. Alexion Pharmaceuticals shares fell 0.25 percent to close at $123.36 on Monday.
  • Societe Generale downgraded Church & Dwight Co., Inc. (NYSE: CHD) from Buy to Hold. Church & Dwight shares fell 0.28 percent to $57.30 in pre-market trading.
  • Piper Jaffray downgraded Hi-Crush Partners LP (NYSE: HCLP) from Overweight to Neutral. Hi-Crush Partners shares fell 1.13 percent to close at $13.10 on Monday.
  • Argus downgraded Wynn Resorts, Limited (NASDAQ: WYNN) from Buy to Hold. Wynn Resorts shares fell 0.29 percent to $152.50 in pre-market trading.
  • Mizuho downgraded SCANA Corporation (NYSE: SCG) from Buy to Neutral. SCANA shares rose 0.14 percent to close at $42.18 on Monday.
  • Ladenburg Thalmann downgraded Kindred Biosciences, Inc. (NASDAQ: KIN) from Buy to Neutral. Kindred Biosciences shares rose 3.69 percent to close at $14.05 on Monday.
  • Raymond James downgraded Gemphire Therapeutics Inc. (NASDAQ: GEMP) from Outperform to Market Perform. Gemphire Therapeutics shares fell 25.07 percent to $5.50 in pre-market trading.
  • Bank of America downgraded Zillow Group, Inc. (NASDAQ: ZG) from Buy to Neutral. Zillow shares fell 17.15 percent to $48.88 in pre-market trading.

 

Top Initiations

  • Stifel Nicolaus initiated coverage on Williams Companies Inc (NYSE: WMB) with a Buy rating. The price target for Williams Companies is set to $35. V shares closed at $31.34 on Monday.
  • Canaccord Genuity initiated Ascendis Pharma A/S (NASDAQ: ASND) with a Buy rating. The price target for Ascendis Pharma is set to $81. Ascendis Pharma shares closed at $66.62 on Monday.
  • Analysts at Stifel Nicolaus initiated coverage on Neurocrine Biosciences, Inc. (NASDAQ: NBIX) with a Buy rating. The price target for Neurocrine Biosciences is set to $137. Neurocrine Biosciences shares closed at $115.89 on Monday.
  • Canaccord Genuity initiated coverage on Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) with a Buy rating. The price target for Deciphera Pharmaceuticals is set to $55. Deciphera Pharmaceuticals closed at $35.96 on Monday.
  • Stifel Nicolaus initiated coverage on Alkermes plc (NASDAQ: ALKS) with a Hold rating. The price target for Alkermes is set to $45. Alkermes shares closed at $45.03 on Monday.
  • Credit Suisse initiated coverage on Chubb Ltd (NYSE: CB) with a Neutral rating. The price target for Chubb is set to $150. Chubb shares closed at $138.70 on Monday.
 

Related Articles (ALKS + ALNY)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
REGIHC Wainwright & Co.Maintains115.0
KRTXJMP SecuritiesMaintains167.0
CVNAJMP SecuritiesMaintains290.0
SHAKPiper SandlerMaintains135.0
ABNBPiper SandlerMaintains198.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com